The evolution of cell and gene therapy is reshaping drug discovery, providing new hope for rare diseases and cancer through innovative gene editing approaches.

The industry is on a strong growth trajectory, with experts predicting notable achievements over the next decade. Forecasts ...

Graphic processing units (GPUs) and artificial intelligence (AI) are among the most searched terms online these days, making ...

The largest gathering of healthcare technology professionals worldwide, HIMSS brings together more than 30,000 attendees to discuss global health topics shaping the next generation of healthcare. John ...

Electromagnetic devices are integral to various sectors, including energy, transportation, communication, and healthcare, impacting everything from power ...

The Dr. Levi Watkins Jr. Medical Accelerated Pathway Program will offer a seven-year medical school option for Tennessee ...

Rezolute , Inc. (NASDAQ:RZLT), a clinical-stage biopharmaceutical company, is making significant strides in the development of its lead drug candidate, ersodetug, for the treatment of congenital ...

Potential delays in clinical trials may result in extended timelines for new drug approvals, and a sudden reduction in ...

Reconstructive surgery, essential for restoring function and appearance after trauma or disease, has undergone significant transformation due to ...

Private equity investors in health care and life sciences must navigate a complex and shifting landscape influenced by regulatory and policy ...

The Trump administration recently announced the National Institutes of Health will make big changes in the way it funds ...

Laboratories would literally go dark,” says a medical research insider, if Trump administration cuts to NIH funding go ...